“SORPO is a well-established company with a distinctive marketing strategy and strong product portfolio, and it was, therefore, a logical selection for us in fulfilling our pan-Baltic expansion strategy,” said Mr. Erki Molder, CEO of MediCap Holding. “We have been looking for a Lithuanian laboratory with suitable business practices and attractive business model for quite some time, and I am extremely glad to close this transaction.”

Sorpo was formerly owned by Fermentas, a company that Thermo Fisher acquired in 2010.

The CEO of SORPO, Mr. Valdemaras Gervinskas, believes this is a very positives change for SORPO: “Quattromed, the portfolio
company of Medicap, is undoubtedly the leading medical laboratory in the Baltic region. We believe that the strong management of MediCap, with financial support from BaltCap, the Baltic’s leading private equity provider and the main
shareholder of MediCap, helps SORPO in fulfilling its growth strategy.”